NCT04983797 - A Study Assessing Arrhythmia Mapping With the Multi-Electrode OPTRELL™ Mapping Catheter | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 25, 2021

Primary Completion Date

November 4, 2021

Study Completion Date

November 4, 2021

Conditions

Scar-related Atrial TachycardiaParoxysmal Atrial FibrillationPersistent Atrial FibrillationTachycardia, VentricularVentricular Premature Complexes

Interventions

DEVICE

OPTRELL Mapping Catheter

Participants scheduled to have a clinically-indicated catheter mapping and ablation using OPTRELL mapping catheter for the management of Atrial procedure (Scar-related Atrial Tachycardia, Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation) and Ventricular procedures (Ventricular Tachycardia, Premature Ventricular Complex).

Trial Locations (3)

2650

UZ Antwerpen, Antwerp

3500

Virga Jessa Ziekenhuis, Hasselt

8661

Vilnius University Hospital Santaros Clinics, Vilnius

All Listed Sponsors

lead

Biosense Webster, Inc.

INDUSTRY